John P. Hamill Insider Profile

11 Followers
John P. Hamill, Interim CFO at Cellectar Biosciences, holds ― shares in Cellectar Biosciences (Ticker: CLRB), holds 19.37K shares in Aprea Therapeutics (Ticker: APRE), holds 72.80K shares in Windtree Therapeutics (Ticker: WINT). Most recently, John P. Hamill ― shares of Cellectar Biosciences on ― for an estimated value of ―.
tipranks
John P. Hamill

John P. Hamill
Cellectar Biosciences (CLRB)
Interim CFO

Ranked #89,074 out of 99,218 Corporate Insiders

Profitable Transactions

38%
3 out of 8 Profitable Transactions

Average Return

-28.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$266K
58.13%
25.85%
16.01%
0.00%
A breakdown of John P. Hamill's holdings

Insider Roles

Trevena
(TRVN)
VP Fin,Princ Fin&Acct Officer
Aprea Therapeutics
(APRE)
SrVP/CFO/Prin Fin & Acct Ofcr
Windtree Therapeutics
(WINT)
SVP & CFO
Cellectar Biosciences
(CLRB)
Interim CFO
Roles that John P. Hamill holds in companies

Most Profitable Insider Trade

Stock:
Aprea Therapeutics
(APRE)
Rating:Informative Buy
Date:Oct 15, 2024 - Today
Return:+28.50%
The most profitable trade made by John P. Hamill

John P. Hamill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cellectar Biosciences
Interim CFO
Trevena
Jun 04, 2019
VP Fin,Princ Fin&Acct Officer
Informative Buy
8.70K
$154.60K
Windtree Therapeutics
Jul 26, 2022
SVP & CFO
Informative Buy
1.08K
$42.59K
Aprea Therapeutics
Oct 16, 2024
SrVP/CFO/Prin Fin & Acct Ofcr
Informative Buy
123.00
$68.76K
List of latest transactions for each holding click on a transaction to see John P. Hamill's performance on stock

John P. Hamill insider profile FAQ

What is the percentage of profitable transactions made by John P. Hamill?
The percentage of profitable transactions made by John P. Hamill is 38%.
    What is the average return per transaction made by John P. Hamill?
    The average return per transaction made by John P. Hamill is -28.40%.
      What stocks does John P. Hamill hold?
      John P. Hamill holds: CLRB, TRVN, WINT, APRE stocks.
        What was John P. Hamill’s latest transaction?
        John P. Hamill latest transaction was an Uninformative Buy of ―.
          What was John P. Hamill's most profitable transaction?
          John P. Hamill’s most profitable transaction was an Informative Buy of APRE stock on October 15, 2024. The return on the trade was 28.50%.
            What is John P. Hamill's role in Cellectar Biosciences?
            John P. Hamill's role in Cellectar Biosciences is Interim CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.